argenx to Report Half Year 2026 Financial Results and Second Quarter Business Update on July 23, 2026
argenx announced it will report its half year 2026 financial results and provide a second quarter business update via a conference call and webcast on July 23, 2026. The company specializes in developing innovative antibody-based treatments for severe autoimmune diseases and plans to discuss progress on its current products and pipeline.